A growing number of Americans are turning to prescription subscription plans as health insurance becomes harder to afford, and Amazon and GoodRx are emerging as early winners. According to a Reuters analysis published on September 29 (syndicated on Yahoo Finance), flat-fee programs that bundle generic drugs and other health services are attracting patients squeezed by rising premiums, higher deductibles and shrinking coverage.
Amazon’s RxPass starts at $5 a month, while the Companion plan from GoodRx costs $14.99. Both give members free access to selected generic medicines, and analysts told Reuters the model can help people save money even when they hold insurance. Reuters noted that it is not clear how many Americans are enrolled in such plans nationwide.
How Amazon RxPass and GoodRx Companion Compare
Amazon’s plan is open to Prime members and covers around 50 generic drugs for $5 a month. GoodRx offers more than 250 generics for $14.99, and its Companion program adds discounts on telehealth and on common vision, dental and lab services. GoodRx launched Companion in May, alongside older subscription programs it already ran.
Amazon says RxPass attracts people with and without health coverage, and many of them choose to pay in cash. John Love, a vice president at Amazon Pharmacy, said customers often use the program to refill mental health and cardiovascular medicines.
Why Prescription Subscription Plans Are Gaining Momentum
Reuters ties the trend to rising premiums and out-of-pocket costs, driven in part by higher prices for medical services. Millions of Americans dropped individual plans sold under the Affordable Care Act in 2026, and benefits consultants expect costs for employers that sponsor most private plans to climb by as much as 11% in 2027.
Investor William Soliman of White Manna Capital Partners said people pushed into high-deductible plans, where thousands of dollars must be spent before coverage starts, often compare cash-pay options with pharmacy prices. In that setting, he said, a simple and predictable $5 fee stands out. GoodRx chief executive Wendy Barnes described Companion as a “complement to insurance” for consumers facing rising deductibles and narrower lists of covered drugs.
For background on the cost pressures behind this shift, read our explainer on why the US healthcare system is expensive and our guide to how pharmaceutical companies price drugs.
Growth Signals From Amazon and GoodRx
Amazon says the number of customers using RxPass has grown nearly threefold since the program launched in 2023, and more than 70% of them fill three or more different medications through it. Love said that pattern shows RxPass is reaching people with ongoing health needs, for whom consistent access to affordable refills matters most.
GoodRx reported that subscription revenue rose 39% to $28.5 million in the second quarter from a year earlier. The company said its subscription plans, which include Companion and older programs, grew 14% in the quarter. Investors have taken notice: shares of GoodRx are up 22% this year and Amazon shares are up 7%, according to Reuters. Truist analyst Jailendra Singh said the subscription model can make a lot of sense for anyone taking several drugs.
Limits and Alternatives Patients Should Weigh
Prescription subscription plans cover only a slice of the market. Amazon’s roughly 50 generics and GoodRx’s 250-plus are a small fraction of the roughly 30,000 drugs approved in the United States. Generic medicines often cost a few dollars a month or less, but some cost far more, so the value of a plan depends on which drugs a person takes and how many.
Competitors are taking different approaches. FreeRx charges $49.95 a month for virtual urgent-care visits and more than 1,000 generics. Mark Cuban’s Cost Plus Drugs sells generics at its acquisition cost plus a 15% markup, and Cuban argues that this pricing beats a subscription over time and undercuts the standard $10 or $15 copay charged by most insurance plans.
Strategic Value for Amazon and GoodRx
Analysts say the subscriptions work as gateways to broader services. Amazon offers Prime members a discount on One Medical primary care, and the plans can steer customers toward Amazon Pharmacy while strengthening Prime loyalty. One investor told Reuters that Amazon could become the front door to healthcare.
Expectations for direct income are modest, however. Investors expect RxPass revenue to stay small against the $828 billion in 2026 revenue that LSEG data projects for Amazon, and an EMarketer analyst said the program’s real value lies in supporting Prime rather than in the monthly fee itself. For more coverage of drug access and pricing, browse our pharmaceuticals news section.
Key Facts at a Glance
- Amazon RxPass: $5 a month for Prime members, around 50 generic drugs
- GoodRx Companion: $14.99 a month, more than 250 generics plus telehealth, vision, dental and lab discounts
- Amazon growth: RxPass users up nearly threefold since 2023, with over 70% filling three or more medications
- GoodRx growth: Q2 subscription revenue up 39% to $28.5 million
- Coverage backdrop: millions dropped ACA individual plans in 2026, and employer plan costs may rise up to 11% in 2027
- Enrollment: total number of subscribers across the industry is unclear
- Source: Reuters, September 29, 2026
Frequently Asked Questions
How much do prescription subscription plans cost?
Amazon RxPass costs $5 a month for Prime members, and GoodRx Companion costs $14.99 a month. FreeRx charges $49.95 a month and adds virtual urgent care.
Who benefits most from a prescription subscription?
Analysts quoted by Reuters say the plans make the most sense for people who take several generic drugs that appear on a plan’s covered list.
Do these plans replace health insurance?
No. GoodRx describes Companion as a complement to insurance, and the plans cover only a limited set of generic medicines.
How many Americans use prescription subscriptions?
That is unclear. Reuters reports that total enrollment across the industry has not been disclosed.
This story is based on Reuters reporting and company statements. It is for information only and is not medical or financial advice; talk to a doctor or pharmacist before changing how you obtain your medicines.